Brunei Darussalam vs United States of America: Proportion of the target population who received the final dose of
Brunei Darussalam
88.0%
in 2024
United States of America
52.0%
in 2024
Brunei Darussalam rank
14th
United States of America rank
12th
Proportion of the target population who received the final dose of over time
- Brunei Darussalam
- United States of America
How they compare
Brunei Darussalam currently reports 88.0% against 52.0% in United States of America, a difference of 36.0%.
That makes Brunei Darussalam's figure about 1.7 times United States of America's.
Across all 13 years both countries report, Brunei Darussalam has been ahead every year.
Brunei Darussalam ranks 14th and United States of America ranks 12th of 107 countries.
Brunei Darussalam has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Brunei Darussalam | United States of America | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 84.8% | 33.8% | 51.0% | Brunei Darussalam |
| 2020s | 88.2% | 50.8% | 37.4% | Brunei Darussalam |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, Brunei Darussalam or United States of America?
- Brunei Darussalam, at 88.0% against 52.0% in United States of America as of 2024.
- What is the difference in proportion of the target population who received the final dose of between Brunei Darussalam and United States of America?
- 36.0%, with Brunei Darussalam ahead.
- How many years of comparable data are there for Brunei Darussalam and United States of America?
- 13 years are reported by both, from 2012 to 2024.
- How do Brunei Darussalam and United States of America rank globally for proportion of the target population who received the final dose of?
- Brunei Darussalam ranks 14th and United States of America ranks 12th of 107 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.